Sentences with phrase «human vaccine for»

There was a human vaccine for Lyme disease until 2002 when it was discontinued.

A research team at The University of Texas at El Paso is one step closer to developing an effective human vaccine for cutaneous leishmaniasis, a tropical disease found in Texas and Oklahoma, and affecting some U.S. troops stationed in Afghanistan and Iraq.

Not exact matches

So far, Inovio has made the most progress with a so - called therapeutic vaccine — one that helps defeat a disease even after a patient has been diagnosed — for human papilloma virus, or HPV.

There are currently two types of cancer vaccines available: preventive, for human papillomavirus and hepatitis B; and treatment, for metastatic prostate cancer.

«We are honored to receive this award which underscores the unique value of our technology platform and its game changing potential to make novel vaccines for important human diseases.»

The only two manufacturers of human rabies vaccine approved for use in the U.S. have experienced production interruptions and other problems that could result in a shortage, health officials warn.

Multiple obstacles stand in the way of this becoming a future universal flu vaccine for humans, scientists from The Scripps Research Institute cautioned in an accompanying commentary in Science.

The company has begun human testing of its mRNA drugs for cardiovascular disease and cancer, and for vaccines against the flu, Zika, and chikungunya viruses.

The pEpitope method accounts for 77 percent of what impacts efficacy of the vaccine in humans.

In all environments and independent of the resource settings, two doses of human papillomavirus vaccine are recommended for girls ages 9 to 14 years, with an interval of at least 6 months and up to 12 to 15 months between doses.

This finding also paves the way for practical applications: the ETH spin - off Malcisbo, which came from the microbiologist's laboratory, endeavours, on the basis of these surface sugar structures to develop novel vaccines against parasites and pathogenic germs for livestock and humans.

«Study offers new recommendations for TB vaccine testing in humans.»

Furthermore, there is no DNA vaccine currently licensed for use among humans.

And by winter several more vaccine candidates that employ various forms of the virus are slated for human testing, supported by funds from the NIH.

Vaccines developed using proteins rather than live viruses can help protect animals and subsequently humans from insect - borne viruses, according to Alan Young, chief scientific officer for Medgene Labs, an animal health company that develops therapeutics and diagnostics, including vVaccines developed using proteins rather than live viruses can help protect animals and subsequently humans from insect - borne viruses, according to Alan Young, chief scientific officer for Medgene Labs, an animal health company that develops therapeutics and diagnostics, including vaccinesvaccines.

An NIH - backed vaccine is among several heading for human trials, but the timeline for large - scale deployment remains murky

In response to the Ebola Zaire outbreak, several of these vaccines have been fast tracked for human use.

Yet there is reason for optimism: the NIH has already developed a DNA vaccine against the West Nile virus that appeared promising in early human studies (although ultimately the NIH could not find a commercial partner to take that vaccine forward).

Roughly a year after Brazilian doctors and researchers first suspected a link between a spate of alarming birth defects and the Zika virus, a cadre of potential vaccines are now headed for testing in humans.

Last year alone, the US Department of Health and Human Services allocated $ 400 million to three centres for producing vaccines against potential bioweapons.

The first vaccine to receive the green light for human trials is a product from Pennsylvania - based Inovio Pharmaceuticals.

Injectable vaccines often require trapping the animal — a costly endeavor that's stressful and dangerous for both wild animals and the humans doing the vaccinating.

Unlike any other vaccine designed for human use, this product would be a DNA vaccine that only contains a particular part of the pathogen (rather than a vaccine with an inactivated live or dead virus, for example).

No drugs or vaccines are yet available for human use.

Merck has developed a vaccine for human papillomavirus, the leading cause of cervical cancer.

Understanding what combination of mutations could transform H5N1 into a human pandemic virus gives epidemiologists a leg up on preparing countermeasures; they can, for example, test existing vaccines against the new strain.

Every year, public health officials survey the three flu subtypes circulating in humans and design a vaccine for the next winter season that covers them all.

«For instance, diagnostic tests could be tailored to different strains or stages of the disease,» and vaccines could be designed to skirt interaction with the human body.

For their research, Pekosz and his team, using human nasal tract cells, studied the weakened strain of the flu virus that is used in the nasal spray vaccine and compared its behavior with that of the flu virus itself.

In September, Roswell Park Cancer Institute in New York and Cuba's Center for Molecular Immunology announced that they would partner to test a cancer vaccine, said Cristina Rabadán - Diehl, director of the Office of the Americas in the Office of Global Affairs, Office of the Secretary at the U.S. Department of Health and Human Services.

Kristien Van Reeth, of Belgium's Ghent University, and collaborators are comparing different vaccines and vaccination strategies in swine, which are used as a model for humans.

Researchers from the University of Zurich and University Hospital Zurich now reveal which factors are responsible for the human body forming such broadly neutralizing HIV antibodies, thereby opening new avenues for the development of an HIV vaccine.

«Several letters [from the Association of American Medical Colleges and others]... suggest that human fetal tissue is used for modern vaccine production.

According to a study published in Human Vaccines & Immunotherapeutics, the Tdap vaccine is safe for both mothers and infants.

The rationale for sequencing and exploring the human genome — to revolutionize the finding of new drugs, diagnostics and vaccines, and to tailor treatments to the genetic make - up of individuals — is the same today.

Testing on chimps has been a huge boon for humans in the past, contributing to the discovery of hepatitis C and vaccines against polio and hepatitis B, among other advances.

The team was led by Barton Haynes, M.D., director of the Duke Center for HIV / AIDS Vaccine Immunology - Immunogen Discovery (CHAVI - ID) and the Duke Human Vaccine Institute, and John Mascola, M.D., director of the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

Last year the National Institutes of Health announced plans to put some 180 ex-Coulston chimps currently housed at the Alamogordo Primate Facility back in service, to rejoin the roughly 800 other chimps that serve as subjects for studies of human diseases, therapies and vaccines in the U.S., which is the only country apart from Gabon to maintain chimps for this purpose.

No vaccine currently exists for HIV (human immunodeficiency virus) and there is no cure for AIDS (acquired immune deficiency syndrome), which currently infects 34 million around the globe.

This study strengthens the argument for focusing on the malaria side of the parasite - human interaction in our search for new vaccine candidates.»

Profectus BioSciences in Tarrytown, New York, which is developing a similar vaccine, needs some $ 2 million to produce it under good manufacturing practice standards, a prerequisite for any human study.

Ding's next goal is to raise $ 5 million so he can spend about five years studying new vaccines for human pathogens such as dengue fever.

Vaccines have treated infectious prions in mice, raising hopes of a cure for the deadly human version of «mad cow disease».

Adenovirus 5 has 50 or so known relatives that infect humans and so in principle could also be used as a basis for vaccines, as could one from a chimpanzee.

Currently, there is no vaccine for the disease in humans.

After the European Medicines Agency's Committee for Medicinal Products for Human Use meeting 19 - 22 October, the agency recommended that everyone regardless of age receive two doses of the pandemic flu vaccines approved for use there.

«Given that approximately 12 percent of human cancers worldwide may be attributed to viruses, and there are no vaccines currently available for these five viruses, prevention strategies to reduce the infections that can lead to cancer are even more critical,» said Linda Birnbaum, Ph.D., director of the National Institute of Environmental Health Sciences (NIEHS) and National Toxicology Program (NTP).

Human safety trials for a vaccine to jump - start immunity could begin later this year; larger efficacy trials may be a year and a half away.

A new experimental vaccine for Ebola is currently undergoing testing in a global clinical trial in humans.

Because there is no vaccine for humans, efforts to curb the disease's spread focus on controlling mosquitoes and their infection rates.